Pharma
Beyond the inhaler: Why the future of COPD care is digital, continuous, and predictive
Inhalers: life-saving, but not enoughFor decades, inhalers have been the cornerstone of COPD care. They improve symptoms and prolong life. But adherence is low — often less than 50% — and monitoring is sporadic. Patients are frequently left unobserved for long stretches, during which th...
The smartphone revolution in lung health: Foundations for the future
Spirometry: A century-old tool in need of reinventionFor more than a century, spirometry has been the foundation of respiratory medicine. Yet despite its clinical importance, the test remains hospital-bound, tied to bulky equipment and reliant on maximal voluntary effort. Patients often...
588 IND Filings Worldwide
We're proud to share that Medicilon has now supported 588 IND filings.
25 Years of Guardtech – a new era for cleanroom furniture & equipment fit-outs with Guardware
Suffolk-based cleanroom construction specialists the Guardtech Group have launched a new cleanroom furniture & equipment website to take their Guardware Cleanroom Hardware brand to the next level. ...
Looking to the future of intratumoural drug delivery
Drug treatments serve as a vital line of defence alongside surgery and radiotherapy. They include chemotherapy, hormone therapy, immunotherapy and targeted therapy. Most drug treatments are delivered systemically, circulating through the bloodstream to reach cancer cells. Systemic cance...
Closed Loop Medicine launches first personalized GLP-1 dosing platform in U.S.
WeDosify becomes CLM’s first commercially available product – delivering data-driven, adaptive dosing recommendations to improve GLP-1 adherence.Informed by 29 studies and 15,000+ patient profiles; developed to tailor GLP-1 titration and reduce side effects. London, UK, September 1...
Taming the untamable: Medicilon Powers KRAS-targeted therapies
KRAS is one of the most frequently mutated oncogenes in human cancers. Once thought “undruggable,” recent scientific advances have enabled the development of therapies targeting KRAS mutations, especially G12C, G12D, and G13D. ...
Milner Institute announces launch of Bio-spark 2025
Early career scientists interested in entrepreneurship can apply for the 2025-26 Bio-spark programme until 13 October. ...
DJR Care comes to The EpiCentre
DJR Care, a facilitator to the healthcare sector, has opened an office at The EpiCentre in Haverhill, focused on enhancing the efficiency and effectiveness of healthcare and residential care services through its own “DJR Care Model”. ...
Free Virtual Workshop: How to Use the Docking Software GOLD to Perform Virtual Screening Simulations
In drug discovery, virtual screening (VS) is a widely used computational technique for identifying hits, optimizing leads, and performing scaffold hopping by searching libraries of small molecules. It can significantly reduce research time and cost through two primary approaches: struct...